Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for Prevention of Emergence Agitation After Pediatric Penile Orthopedic Surgery
ChiCTR2500095513Phase 4Not yet recruiting
- Sponsor
- Foshan Maternity & Child Healthcare Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine (2 arms), sponsored by Foshan Maternity & Child Healthcare Hospital. Primary endpoint: Restlessness Assessment Scale for Awakening (PAED) score. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
nalbuphine
Beyond the preview
Go deeper on ChiCTR2500095513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095513.